3 Anticoagulant Safety

Core safety principles

Anticoagulants reduce clot formation, but incorrect selection, dosing, or administration can cause serious bleeding. Safe nursing practice includes confirming the indication and dose, checking relevant laboratory results and patient factors, recognizing bleeding or thrombosis, and teaching patients how to take the medication safely.

Follow the prescriber’s orders and facility protocols. Do not independently start, stop, or adjust anticoagulant treatment.

Verification and administration

Before administration, verify the medication’s indication and prescribed dose. Review relevant laboratory results and renal function when appropriate for the drug, consider other medications including over-the-counter drugs and supplements, and assess for signs of bleeding or a recent fall or injury.

Monitoring is medication-specific. INR monitoring is used for warfarin, not routinely for every anticoagulant; use the medication-specific order and monitoring protocol.

Unfractionated heparin infusions

Unfractionated heparin is a high-alert medication. For a weight-based infusion, verify the patient’s weight, concentration, calculations, pump settings, and required laboratory monitoring against the order and facility protocol. Do not calculate from ideal body weight without checking the order, apply one aPTT target to every patient and facility, or adjust the infusion independently when a result is outside the target range.

Monitoring may use aPTT or anti-Xa, depending on the protocol and clinical circumstances. Use the institution’s protocol for monitoring and titration.

Warfarin monitoring and teaching

INR testing helps the clinician assess warfarin’s effect and guide the dose. The target and testing schedule depend on the patient’s indication and treatment plan, and ongoing monitoring remains important, even when the INR is in range.

Patients taking warfarin should generally keep vitamin K intake consistent rather than avoid vitamin K foods altogether. They should check with their clinician or pharmacist before starting a new medicine or supplement, and tell healthcare professionals, including dentists, that they take warfarin.

If a dose is missed, patients should seek instructions rather than double the next dose.

Direct oral anticoagulants

Routine INR monitoring is not used to adjust apixaban. However, clinical follow-up and appropriate laboratory monitoring remain important; the care team may monitor kidney function, blood counts, and other factors.

Patients should not stop a DOAC without instructions. A lack of routine INR-based dose adjustment does not mean that no monitoring is needed.

Recognizing bleeding and responding

Black, tarry stool and dizziness may signal significant gastrointestinal bleeding or blood loss. Assess promptly and escalate for urgent evaluation according to emergency procedures; do not reassure the patient that this is expected, recommend an over-the-counter pain reliever, or make unsupervised changes to the anticoagulant plan.

Patients should promptly report unusual bleeding, blood in urine or stool, severe headache, or a significant fall or head injury. A significant injury, especially a head injury, requires prompt assessment.

Life-threatening bleeding

Escalate immediately and support emergency assessment and stabilization. Provide the medication name and time of the last dose if known. Do not delay urgent care while waiting for a routine INR result.

Reversal depends on the anticoagulant and clinical situation. Vitamin K reverses warfarin, not all anticoagulants. For factor Xa inhibitor bleeding, follow current facility protocols and specialist guidance; do not assume a specific reversal product is available. In the United States, Andexxa (andexanet alfa) was no longer manufactured for or sold after December 22, 2025.

Patient teaching and injury prevention

Teach patients to check with their care team before using medicines that may increase bleeding risk, including aspirin or ibuprofen, or before changing anticoagulant treatment. They should not stop the medication before dental work or another procedure without contacting the prescriber, and should inform healthcare professionals about their anticoagulant before procedures.

Emphasize prompt reporting of possible bleeding and significant injuries. Patients should follow instructions from their care team rather than independently changing a dose or stopping treatment.